Industry »Biotechnology« (200+)
Filter by Size, Price, EPS, Revenue, Debt, Returns and many other Dividend and Fundamental Data.
Results
200 matches
| SYMBOL | INDUSTRY | MKT CAP | VRT | SIGNAL | SAFETY | RS | DIV. YIELD |
|---|---|---|---|---|---|---|---|
| VRTX NASDAQ Vertex Pharmaceuticals |
Biotechnology
Cystic Fibrosis Drugs, Gene |
110B | 49 | -0.62 | 77 | 27 | - |
| REGN NASDAQ Regeneron Pharmaceuticals |
Biotechnology
Ophthalmology Drugs, Immunology |
67.4B | 51 | -0.31 | 83 | 19 | 0.7% |
| ARGX NASDAQ argenx |
Biotechnology
Autoimmune Therapies, Monoclonal |
49.6B | 61 | 0.02 | 79 | 49 | - |
| ALNY NASDAQ Alnylam Pharmaceuticals |
Biotechnology
RNAi Therapeutics, Rare Disease |
38.3B | 45 | -0.63 | 46 | 11 | - |
| RVMD NASDAQ Revolution Medicines |
Biotechnology
Oncology Drugs, RAS Inhibitors |
32.0B | 39 | -0.33 | 72 | 98 | - |
| RPRX NASDAQ Royalty Pharma |
Pharmaceuticals
Drug Royalties, Innovation |
30.8B | 54 | 0.81 | 35 | 84 | 2.8% |
| ONC NASDAQ BeiGene |
Biotechnology
Small Molecule Inhibitors |
30.4B | 55 | 0.11 | 44 | 26 | - |
| INSM NASDAQ Insmed |
Biotechnology
Antibiotics, Enzyme Inhibitors |
23.7B | 28 | -0.80 | 35 | 12 | - |
| BNTX NASDAQ BioNTech SE |
Biotechnology
mRNA Vaccines, Oncology Drugs |
22.9B | 33 | -0.67 | 84 | 14 | - |
| ROIV NASDAQ Roivant Sciences |
Biotechnology
Monoclonal Antibodies, Small |
22.4B | 47 | 0.45 | 72 | 94 | - |
| INCY NASDAQ Incyte |
Biotechnology
Oncology Drugs, Kinase Inhibitors |
19.5B | 72 | -0.29 | 84 | 50 | - |
| MRNA NASDAQ Moderna |
Biotechnology
mRNA Vaccines, Cancer |
18.8B | 45 | -0.09 | 82 | 86 | - |
| GMAB NASDAQ Genmab AS |
Biotechnology
Antibodies, Cancer Therapies |
16.7B | 58 | -0.37 | 68 | 34 | - |
| JAZZ NASDAQ Jazz Pharmaceuticals |
Pharmaceuticals
Sleep Medicine, Oncology |
15.0B | 61 | 1.06 | 72 | 91 | - |
| ASND NASDAQ Ascendis Pharma AS |
Biotechnology
Growth Hormones, Endocrinology |
14.9B | 47 | 0.03 | 33 | 72 | - |
| BBIO NASDAQ BridgeBio Pharma |
Biotechnology
Genetic Medicines, TTR |
12.9B | 35 | -0.54 | 32 | 78 | - |
| IONS NASDAQ Ionis Pharmaceuticals |
Biotechnology
RNA Medicines, Biotechnology |
12.6B | 44 | 0.16 | 54 | 82 | - |
| EXEL NASDAQ Exelixis |
Biotechnology
Oncology Medicines, Kinase |
12.5B | 64 | 0.73 | 87 | 68 | - |
| SMMT NASDAQ Summit Therapeutics |
Biotechnology
Bispecific Antibodies |
12.2B | 18 | -0.60 | 72 | 12 | - |
| AXSM NASDAQ Axsome Therapeutics |
Pharmaceuticals
Antidepressants, Sleep |
12.0B | 38 | 0.26 | 38 | 92 | - |
| MDGL NASDAQ Madrigal Pharmaceuticals |
Biotechnology
Liver Therapeutics, Metabolic |
11.8B | 35 | -0.68 | 33 | 76 | - |
| ARWR NASDAQ Arrowhead Pharmaceuticals |
Biotechnology
RNAi Therapeutics, Genetic |
10.6B | 36 | 0.25 | 34 | 98 | - |
| CYTK NASDAQ Cytokinetics |
Biotechnology
Muscle Activators, Muscle |
10.6B | 39 | 0.21 | 33 | 90 | - |
| BMRN NASDAQ Biomarin Pharmaceutical |
Biotechnology
Enzyme Therapies, Growth |
10.5B | 38 | -0.16 | 81 | 18 | - |
| ABVX PA Abivax |
Biotechnology
Anti-Inflammatory Drugs |
9.48B | 38 | -0.38 | 72 | 99 | - |
| PRAX NASDAQ Praxis Precision Medicines |
Biotechnology
Small Molecules, Antisense |
9.36B | 45 | -0.09 | 61 | 99 | - |
| ABVX NASDAQ Abivax American Depositary |
Biotechnology
Immunotherapies, Anti-Inflammatory |
9.00B | 41 | -0.40 | 72 | 99 | - |
| KRYS NASDAQ Krystal Biotech |
Biotechnology
Gene Therapies, Topical Gels |
8.78B | 66 | -0.11 | 69 | 90 | - |
| IBRX NASDAQ Immunitybio |
Biotechnology
Immunotherapies, Cytokine Fusion |
8.09B | 37 | -0.44 | 30 | 96 | - |
| NUVL NASDAQ Nuvalent |
Biotechnology
Kinase Inhibitors, Oncology |
7.99B | 28 | -0.76 | 51 | 57 | - |
| HALO NASDAQ Halozyme Therapeutics |
Biotechnology
Enzymes, Drug Delivery, Injectable |
7.96B | 69 | -0.48 | 81 | 34 | - |
| IMVT NASDAQ Immunovant |
Biotechnology
Monoclonal Antibodies, Immunology |
7.30B | 35 | 0.18 | 26 | 93 | - |
| TECH NASDAQ Bio-Techne |
Life Sciences Tools
Reagents, Antibodies |
6.96B | 39 | -0.47 | 76 | 15 | 0.8% |
| CELC NASDAQ Celcuity |
Biotechnology
Cancer Therapies, Kinase |
6.82B | 46 | 0.23 | 72 | 99 | - |
| PCVX NASDAQ Vaxcyte |
Biotechnology
Pneumococcal Vaccines, Conjugate |
6.81B | 21 | -1.14 | 30 | 46 | - |
| PTGX NASDAQ Protagonist Therapeutics |
Biotechnology
Oral Peptides, Hormone Mimetics |
6.53B | 34 | -0.34 | 28 | 86 | - |
| SYRE NASDAQ Spyre Therapeutics |
Biotechnology
Monoclonal Antibodies |
6.45B | 41 | 0.43 | 55 | 99 | - |
| KYMR NASDAQ Kymera Therapeutics |
Biotechnology
Protein Degraders, Small |
6.43B | 48 | 0.05 | 72 | 87 | - |
| CNTA NASDAQ Centessa Pharmaceuticals |
Biotechnology
Orexin Agonists, Neuroscience |
6.16B | 41 | 0.74 | 64 | 95 | - |
| RYTM NASDAQ Rhythm Pharmaceuticals |
Biotechnology
Peptide Therapeutics, Obesity |
6.14B | 30 | -0.94 | 37 | 26 | - |
| APGE NASDAQ Apogee Therapeutics, Common |
Biotechnology
Monoclonal Antibodies, Biologics |
6.12B | 43 | 0.06 | 70 | 88 | - |
| TGTX NASDAQ TG Therapeutics |
Biotechnology
Monoclonal Antibodies, Multiple |
6.09B | 38 | 0.04 | 37 | 74 | - |
| PTCT NASDAQ PTC Therapeutics |
Biotechnology
Rare Disease Medicines, Gene |
5.93B | 33 | 0.04 | 34 | 58 | - |
| CORT NASDAQ Corcept Therapeutics |
Pharmaceuticals
Cortisol Modulators, Hyperglycemia |
5.92B | 46 | 0.69 | 84 | 65 | - |
| MIRM NASDAQ Mirum Pharmaceuticals |
Biotechnology
Bile Acid Inhibitors, Rare Disease |
5.91B | 33 | -0.90 | 39 | 82 | - |
| BLTE NASDAQ Belite Bio |
Biotechnology
Retinal Therapeutics, Liver Drugs |
5.72B | 32 | -0.48 | 62 | 81 | - |
| SRRK NASDAQ Scholar Rock Holding |
Biotechnology
Monoclonal Antibodies, Myostatin |
5.68B | 38 | -0.64 | 72 | 72 | - |
| COGT NASDAQ Cogent Biosciences |
Biotechnology
Kinase Inhibitors, Precision |
5.58B | 47 | -0.46 | 66 | 97 | - |
| CGON NASDAQ CG Oncology, Common stock |
Biotechnology
Oncolytic Immunotherapy, Bladder |
5.55B | 33 | -0.45 | 30 | 93 | - |
| XENE NASDAQ Xenon Pharmaceuticals |
Biotechnology
Epilepsy Therapeutics |
5.23B | 42 | -0.32 | 83 | 84 | - |
| LEGN NASDAQ Legend Biotech |
Biotechnology
Cell Therapies, CAR-T, Oncology |
5.12B | 27 | 0.27 | 39 | 67 | - |
| DNTH NASDAQ Dianthus Therapeutics |
Biotechnology
Monoclonal Antibodies, Fusion |
4.85B | 42 | 0.07 | 33 | 98 | - |
| CRSP NASDAQ Crispr Therapeutics |
Biotechnology
Gene Editing, Cell Therapies |
4.64B | 22 | -0.30 | 62 | 37 | - |
| LGND NASDAQ Ligand Pharmaceuticals |
Biotechnology
Drug Delivery, Licensed Assets |
4.36B | 58 | 0.03 | 78 | 86 | - |
| MANE NYSE Veradermics |
Biotechnology
Hair Loss Treatments |
4.31B | 44 | 0.37 | 64 | 98 | - |
| CAI NASDAQ Caris Life Sciences, Common |
Life Sciences Tools
Molecular Profiling, Genetic |
4.27B | 24 | -1.27 | 15 | 3 | - |
| NAMS NASDAQ NewAmsterdam Pharma |
Biotechnology
Cardiovascular Drugs, Cholesterol |
4.18B | 32 | -0.53 | 33 | 74 | - |
| TVTX NASDAQ Travere Therapeutics |
Biotechnology
Kidney Medications, Metabolic |
3.93B | 56 | 0.44 | 37 | 95 | - |
| CPRX NASDAQ Catalyst Pharmaceuticals |
Biotechnology
Muscle Disease Drugs, Epilepsy |
3.83B | 63 | 0.67 | 79 | 81 | - |
| CRNX NASDAQ Crinetics Pharmaceuticals |
Biotechnology
Endocrine Therapeutics, Hormone |
3.68B | 23 | -0.86 | 34 | 27 | - |
| ACAD NASDAQ ACADIA Pharmaceuticals |
Biotechnology
Psychosis Medication, Neurological |
3.54B | 28 | -1.01 | 28 | 14 | - |
| ORKA NASDAQ Oruka Therapeutics |
Biotechnology
Monoclonal Antibodies, Psoriasis |
3.52B | 44 | 0.87 | 68 | 99 | - |
| EWTX NASDAQ Edgewise Therapeutics |
Biotechnology
Small Molecules, Muscle Therapies |
3.41B | 43 | -0.02 | 72 | 91 | - |
| VKTX NASDAQ Viking Therapeutics |
Biotechnology
Obesity Drugs, Liver Therapies |
3.31B | 18 | -0.92 | 63 | 28 | - |
| TNGX NASDAQ Tango Therapeutics |
Biotechnology
Oncology Drugs, PRMT5 Inhibitors |
3.07B | 46 | -0.45 | 72 | 99 | - |
| DNLI NASDAQ Denali Therapeutics |
Biotechnology
Neurodegenerative Drugs, Lysosomal |
2.99B | 27 | -0.46 | 60 | 44 | - |
| RCUS NYSE Arcus Biosciences |
Biotechnology
Cancer Therapies, Antibodies |
2.99B | 40 | -0.42 | 33 | 92 | - |
| ALMS NASDAQ Alumis |
Biotechnology
TYK2 Inhibitors, Monoclonal |
2.92B | 41 | 0.23 | 27 | 98 | - |
| BEAM NASDAQ Beam Therapeutics |
Biotechnology
Gene Editing, Stem Cell Therapy |
2.79B | 39 | -0.76 | 63 | 80 | - |
| TARS NASDAQ Tarsus Pharmaceuticals |
Pharmaceuticals
Eye Drops, Antibiotics, Infectious |
2.79B | 39 | -0.95 | 54 | 34 | - |
| SLNO NASDAQ Soleno Therapeutics |
Biotechnology
Rare Disease Drugs |
2.76B | 48 | 0.00 | 71 | 44 | - |
| DYN NASDAQ Dyne Therapeutics |
Biotechnology
Oligonucleotides, Muscle |
2.63B | 37 | -0.55 | 72 | 67 | - |
| IDYA NASDAQ Ideaya Biosciences |
Biotechnology
Oncology Therapeutics, Precision |
2.61B | 25 | -1.09 | 25 | 45 | - |
| ELVN NASDAQ Enliven Therapeutics |
Pharmaceuticals
Kinase Inhibitors, Small |
2.57B | 42 | -0.09 | 61 | 95 | - |
| GPCR NASDAQ Structure Therapeutics |
Biotechnology
Obesity Drugs, Diabetes |
2.57B | 38 | -0.02 | 66 | 66 | - |
| IRON NASDAQ Disc Medicine |
Biotechnology
Hematology Drugs, Anemia |
2.55B | 31 | -0.49 | 69 | 43 | - |
| ARQT NASDAQ Arcutis Biotherapeutics |
Biotechnology
Topical Creams, Therapeutic Foams |
2.51B | 45 | -0.93 | 38 | 35 | - |
| NBTX NASDAQ Nanobiotix |
Biotechnology
Nanoparticles, Cancer |
2.50B | 41 | 0.04 | 28 | 99 | - |
| RLAY NASDAQ Relay Therapeutics |
Biotechnology
Oncology Drugs, Small Molecules |
2.49B | 48 | -0.15 | 70 | 98 | - |
| VERA NASDAQ Vera Therapeutics |
Biotechnology
Fusion Proteins, Monoclonal |
2.47B | 35 | -1.16 | 70 | 70 | - |
| CLDX NASDAQ Celldex Therapeutics |
Biotechnology
Monoclonal Antibodies, Bispecific |
2.40B | 32 | -0.24 | 32 | 79 | - |
| NKTR NASDAQ Nektar Therapeutics |
Pharmaceuticals
Immunotherapies, Autoimmune |
2.39B | 37 | -0.06 | 31 | 98 | - |
| IMNM NASDAQ Immunome |
Biotechnology
Antibody-Drug Conjugates, Oncology |
2.36B | 45 | -0.20 | 66 | 89 | - |
| MLYS NASDAQ Mineralys Therapeutics |
Biotechnology
Hypertension Drugs, Kidney |
2.35B | 42 | -0.68 | 61 | 80 | - |
| KOD NASDAQ Kodiak Sciences |
Biotechnology
Retinal Therapeutics, Antibody |
2.32B | 44 | 0.09 | 71 | 99 | - |
| NANO PA Nanobiotix S.A |
Biotechnology
Nanoparticles, Cancer |
2.23B | 38 | 0.61 | 38 | 99 | - |
| RARE NASDAQ Ultragenyx |
Biotechnology
Antibodies, Enzyme Therapies, Gene |
2.21B | 16 | -1.21 | 38 | 12 | - |
| DFTX NASDAQ Definium Therapeutics |
Pharmaceuticals
Psychedelics, Antidepressants |
2.14B | 40 | -0.25 | 55 | 95 | - |
| ZLAB NASDAQ Zai Lab |
Biotechnology
Oncology Drugs, Immunology |
2.13B | 10 | -0.84 | 17 | 8 | - |
| TYRA NASDAQ Tyra Biosciences |
Biotechnology
Precision Medicines, Oncology |
2.06B | 39 | -0.60 | 50 | 95 | - |
| PHVS NASDAQ Pharvaris BV |
Biotechnology
Angioedema Therapies, Receptor |
2.02B | 37 | -0.42 | 72 | 77 | - |
| PHM MC Pharma Mar S.A. |
Biotechnology
Oncology Drugs, Cancer Treatments |
2.02B | 65 | 0.18 | 74 | 74 | 1.0% |
| TRVI NASDAQ Trevi Therapeutics |
Pharmaceuticals
Chronic Cough Treatment |
1.97B | 39 | -0.48 | 64 | 90 | - |
| AUPH NASDAQ Aurinia Pharmaceuticals |
Biotechnology
Immunosuppressants, Autoimmune |
1.97B | 55 | 0.18 | 34 | 71 | - |
| ADMA NASDAQ ADMA Biologics |
Biotechnology
Immune Globulin, Polyclonal |
1.96B | 39 | -0.91 | 92 | 1 | - |
| VRDN NASDAQ Viridian Therapeutics |
Biotechnology
Monoclonal Antibodies, IGF-1R |
1.95B | 30 | -0.82 | 69 | 8 | - |
| STOK NASDAQ Stoke Therapeutics |
Biotechnology
Antisense Oligonucleotides |
1.89B | 37 | -0.18 | 33 | 85 | - |
| MESO NASDAQ Mesoblast |
Biotechnology
Cell Therapies, Regenerative |
1.88B | 11 | -0.57 | 34 | 39 | - |
| OCS NASDAQ Oculis Holding Ordinary |
Biotechnology
Eye Drops, Biopharmaceuticals |
1.87B | 32 | -0.38 | 37 | 82 | - |
| GLPG NASDAQ Galapagos |
Biotechnology
Immunology Drugs, Oncology Drugs |
1.86B | 32 | -0.89 | 68 | 13 | - |
| SRPT NASDAQ Sarepta Therapeutics |
Biotechnology
Gene Therapy, RNA Therapeutics |
1.85B | 34 | -0.62 | 28 | 9 | - |
| OCUL NASDAQ Ocular Therapeutix |
Pharmaceuticals
Ophthalmic Inserts, Hydrogel |
1.83B | 15 | -0.98 | 37 | 15 | - |
| HRMY NASDAQ Harmony Biosciences Holdings |
Pharmaceuticals
Narcolepsy Drugs, Neurological |
1.82B | 51 | -0.70 | 93 | 23 | - |
| SION NASDAQ Sionna Therapeutics, Common |
Biotechnology
Cystic Fibrosis Drugs, CFTR |
1.82B | 43 | -0.19 | 71 | 91 | - |
| VCEL NASDAQ Vericel Ord |
Biotechnology
Cartilage Implants, Skin |
1.81B | 45 | -0.57 | 62 | 16 | - |
| NTLA NASDAQ Intellia Therapeutics |
Biotechnology
Gene Editing, CRISPR Technology |
1.81B | 25 | -0.03 | 24 | 69 | - |
| GLPG AS Galapagos |
Biotechnology
Oncology Drugs, Immunology Drugs |
1.81B | 39 | -0.49 | 47 | 14 | - |
| ZYME NASDAQ Zymeworks Common Stock |
Biotechnology
Bispecific Antibodies |
1.79B | 35 | -0.01 | 23 | 85 | - |
| SNDX NASDAQ Syndax Pharmaceuticals |
Biotechnology
Menin Inhibitors, Monoclonal |
1.78B | 32 | -0.37 | 22 | 72 | - |
| ANAB NASDAQ AnaptysBio |
Biotechnology
Monoclonal Antibodies, Immunology |
1.76B | 52 | 0.60 | 31 | 99 | - |
| CAPR NASDAQ Capricor Therapeutics |
Biotechnology
Cell Therapies, Exosome Platforms |
1.71B | 45 | -0.07 | 73 | 99 | - |
| QURE NASDAQ Uniqure |
Biotechnology
Gene Therapies, Rare Disease |
1.71B | 30 | -0.18 | 34 | 69 | - |
| RAPP NASDAQ Rapport Therapeutics |
Pharmaceuticals
Small Molecules, CNS Medicines |
1.68B | 53 | -0.36 | 62 | 95 | - |
| AGIO NASDAQ Agios Pharm |
Biotechnology
Metabolic Medicines, Enzyme |
1.68B | 23 | -0.04 | 25 | 19 | - |
| SLS NASDAQ Sellas Life Sciences |
Biotechnology
Immunotherapies, Cancer Vaccines |
1.67B | 43 | 0.33 | 64 | 99 | - |
| NRIX NASDAQ Nurix Therapeutics |
Biotechnology
BTK Degraders, CBL-B Inhibitors |
1.64B | 36 | -0.20 | 32 | 81 | - |
| PVLA NASDAQ Palvella Therapeutics |
Biotechnology
Genetic Skin, Rare Diseases |
1.64B | 42 | -0.76 | 65 | 97 | - |
| MRVI NASDAQ Maravai Lifesciences |
Life Sciences Tools
Nucleic Acids, Capping |
1.63B | 52 | 0.17 | 59 | 89 | - |
| INVA NASDAQ Innoviva |
Pharmaceuticals
Respiratory Medicines |
1.60B | 52 | 0.23 | 66 | 43 | - |
| RXRX NASDAQ Recursion Pharmaceuticals |
Biotechnology
Oncology Drugs, Genetic Medicines |
1.58B | 15 | -0.49 | 31 | 6 | - |
| TSHA NASDAQ Taysha Gene Therapies |
Biotechnology
Gene Therapies, Viral Vectors |
1.58B | 43 | -0.04 | 69 | 86 | - |
| MBX NASDAQ MBX Biosciences, Common |
Biotechnology
Peptide Therapies, Endocrine |
1.56B | 38 | -0.08 | 47 | 88 | - |
| IOVA NASDAQ Iovance Biotherapeutics |
Biotechnology
Cell Therapies, Immunotherapy |
1.54B | 38 | 0.08 | 32 | 92 | - |
| ARDX NASDAQ Ardelyx |
Biotechnology
Gastrointestinal Medicine, Kidney |
1.54B | 32 | -1.18 | 30 | 63 | - |
| GLUE NASDAQ Monte Rosa Therapeutics |
Biotechnology
Molecular Glue Degraders, Small |
1.52B | 40 | -0.26 | 34 | 97 | - |
| IMTX NASDAQ Immatics |
Biotechnology
Cell Therapies, TCR Bispecifics |
1.49B | 36 | -0.27 | 26 | 89 | - |
| PGEN NASDAQ Precigen |
Biotechnology
Gene Therapies, Cell Therapies |
1.48B | 40 | -0.13 | 24 | 86 | - |
| ATAI NASDAQ ATAI Life Sciences BV |
Biotechnology
Psychedelics, Mental Health Drugs |
1.48B | 36 | -0.40 | 25 | 77 | - |
| NVAX NASDAQ Novavax |
Biotechnology
Vaccines, Adjuvants, Infectious |
1.48B | 28 | -0.77 | 33 | 64 | - |
| GHRS NASDAQ GH Research |
Biotechnology
Psychedelics, Inhalable Therapies |
1.47B | 42 | -0.74 | 59 | 91 | - |
| NUVB NYSE Nuvation Bio |
Biotechnology
Cancer Therapeutics, ROS1 |
1.47B | 46 | -0.12 | 31 | 72 | - |
| IMCR NASDAQ Immunocore Holdings |
Biotechnology
Cancer Immunotherapies, T-Cell |
1.44B | 18 | -0.61 | 49 | 13 | - |
| VIR NASDAQ Vir Biotechnology |
Biotechnology
Monoclonal Antibodies, Antivirals |
1.44B | 33 | 0.51 | 24 | 90 | - |
| URGN NASDAQ UroGen Pharma |
Biotechnology
Bladder Cancer Drugs, Hydrogel |
1.43B | 51 | 0.15 | 34 | 98 | - |
| KALV NASDAQ Kalvista Pharmaceuticals |
Biotechnology
Oral Therapies, Enzyme Inhibitors |
1.43B | 50 | 1.12 | 64 | 95 | - |
| MAZE NASDAQ Maze Therapeutics, Common |
Pharmaceuticals
Small Molecules, Kidney Medicine |
1.41B | 43 | 0.03 | 72 | 75 | - |
| BCAX NASDAQ Bicara Therapeutics Common |
Biotechnology
Bifunctional Antibodies, Cancer |
1.34B | 28 | -0.63 | 29 | 84 | - |
| MPLT NASDAQ MapLight Therapeutics |
Biotechnology
Neurological Pharmaceuticals |
1.33B | 45 | -0.54 | 62 | 92 | - |
| MLTX NASDAQ MoonLake Immunotherapeutics |
Biotechnology
Biotechnology, Immunotherapies |
1.29B | 21 | -0.32 | 72 | 10 | - |
| FTRE NASDAQ Fortrea Holdings |
Life Sciences Tools
Clinical Trials, Pharmacology |
1.29B | 42 | -0.30 | 31 | 91 | - |
| BHVN NYSE Biohaven Pharmaceutical |
Biotechnology
Neuroscience Drugs, Immunology |
1.28B | 22 | -0.59 | 62 | 7 | - |
| ABCL NASDAQ Abcellera Biologics |
Biotechnology
Antibodies, Discovery Platform |
1.27B | 46 | 0.30 | 57 | 93 | - |
| AVBP NASDAQ ArriVent BioPharma, Common |
Biotechnology
Kinase Inhibitors, Antibody Drug |
1.26B | 31 | -1.20 | 40 | 73 | - |
| WVE NASDAQ Wave Life Sciences |
Pharmaceuticals
RNA Medicines, Oligonucleotides |
1.24B | 21 | -0.41 | 51 | 4 | - |
| SEPN NASDAQ Septerna, Common Stock |
Pharmaceuticals
Small Molecules, GPCR Agonists |
1.21B | 44 | -0.89 | 32 | 92 | - |
| OLMA NASDAQ Olema Pharmaceuticals |
Biotechnology
Breast Cancer Therapies, Estrogen |
1.19B | 42 | 0.08 | 64 | 81 | - |
| IVA PA Inventiva S.A |
Biotechnology
Small Molecules, MASH Therapies |
1.16B | 36 | -0.70 | 34 | 51 | - |
| ZBIO NASDAQ Zenas BioPharma, Common |
Biotechnology
Monoclonal Antibodies, Immunology |
1.16B | 31 | -0.64 | 55 | 21 | - |
| DBV PA DBV Technologies S.A. |
Biotechnology
Immunotherapy Patches, Allergy |
1.11B | 35 | -0.39 | 34 | 84 | - |
| DBVT NASDAQ DBV Technologies |
Biotechnology
Immunotherapy Patches, Allergy |
1.10B | 45 | -0.04 | 65 | 83 | - |
| MEDCL PA Medincell |
Biotechnology
Injectable Pharmaceuticals, Drug |
1.09B | 48 | -0.14 | 33 | 77 | - |
| AKTS NASDAQ Aktis Oncology, Common stock |
Biotechnology
Radiopharmaceuticals, Targeted |
1.08B | 25 | -0.46 | 58 | 24 | - |
| CRVS NASDAQ Corvus Pharmaceuticals |
Biotechnology
ITK Inhibitors, A2A Antagonists |
1.07B | 42 | -0.41 | 64 | 93 | - |
| MNKD NASDAQ MannKind |
Biotechnology
Inhaled Insulin, Delivery Devices |
1.02B | 17 | -0.36 | 27 | 4 | - |
| DRTS NASDAQ Alpha Tau Medical |
Biotechnology
Radiation Therapy, Medical |
1.00B | 49 | -0.77 | 69 | 98 | - |
| KURA NASDAQ Kura Oncology |
Biotechnology
Menin Inhibitors |
1.00B | 37 | -0.26 | 27 | 83 | - |
| EYPT NASDAQ Eyepoint Pharmaceuticals |
Pharmaceuticals
Retinal Therapeutics, Drug |
991M | 31 | -1.44 | 33 | 64 | - |
| LXRX NASDAQ Lexicon Pharmaceuticals |
Biotechnology
Heart Failure Drugs, Diabetes |
991M | 42 | 0.11 | 29 | 95 | - |
| SVRA NASDAQ Savara |
Biotechnology
Inhaled Biopharmaceuticals |
980M | 41 | -0.86 | 37 | 70 | - |
| PHAT NASDAQ Phathom Pharmaceuticals |
Pharmaceuticals
Acid Blockers, Gastritis |
947M | 43 | -1.06 | 37 | 77 | - |
| CGEM NASDAQ Cullinan Oncology |
Biotechnology
Bispecific Antibodies, Small |
937M | 42 | -0.20 | 59 | 78 | - |
| PHARM AS Pharming |
Biotechnology
Rare Disease Medicines, Protein |
919M | 36 | -0.09 | 54 | 17 | - |
| MGTX NASDAQ MeiraGTx Holdings |
Biotechnology
Gene Therapies, Viral Vectors |
887M | 34 | -0.85 | 27 | 80 | - |
| OMER NASDAQ Omeros |
Pharmaceuticals
Immunology Therapeutics, Protein |
887M | 51 | 0.48 | 31 | 94 | - |
| ORIC NASDAQ Oric Pharmaceuticals |
Biotechnology
Cancer Therapies, Kinase |
871M | 26 | -0.92 | 64 | 14 | - |
| ABUS NASDAQ Arbutus Biopharma |
Biotechnology
RNAi Therapeutics, PD-L1 |
858M | 52 | -0.24 | 26 | 53 | - |
| SANA NASDAQ Sana Biotechnology |
Biotechnology
Cell Therapies, Gene Engineering |
854M | 27 | -0.84 | 57 | 22 | - |
| JANX NASDAQ Janux Therapeutics |
Biotechnology
Immunotherapies, Cancer |
842M | 14 | -0.06 | 30 | 6 | - |
| TBPH NASDAQ Theravance Biopharma |
Pharmaceuticals
Nebulized Bronchodilators |
836M | 40 | -0.74 | 30 | 50 | - |
| XNCR NASDAQ Xencor |
Biotechnology
Monoclonal Antibodies, Bispecific |
836M | 22 | -1.22 | 31 | 48 | - |
| GERN NASDAQ Geron |
Biotechnology
Telomerase Inhibitors, Oncology |
828M | 19 | -0.59 | 24 | 13 | - |
| ANNX NASDAQ Annexon |
Biotechnology
Monoclonal Antibodies, Small |
826M | 50 | 0.54 | 72 | 91 | - |
| VOR NASDAQ Vor Biopharma |
Biotechnology
Fusion Proteins, Immunotherapies |
822M | 48 | -0.05 | 66 | 89 | - |
| CTMX NASDAQ CytomX Therapeutics |
Biotechnology
Antibody-Drug Conjugates, T-Cell |
820M | 31 | -0.35 | 39 | 65 | - |
| DRUG NASDAQ Bright Minds Biosciences |
Biotechnology
Serotonin Agonists, Epilepsy |
804M | 43 | 0.21 | 72 | 90 | - |
| LBRX NASDAQ LB Pharmaceuticals Common |
Pharmaceuticals
Antipsychotics, Neuropsychiatric |
803M | 34 | -0.45 | 27 | 86 | - |
| EVMN NYSE Evommune |
Biotechnology
Anti-Inflammatory Drugs |
788M | 23 | -0.66 | 52 | 35 | - |
| ABSI NASDAQ Absci |
Biotechnology
Antibody Therapeutics |
762M | 41 | 0.15 | 61 | 95 | - |
| AURA NASDAQ Aura Biosciences |
Biotechnology
Ocular Oncology, Bladder Cancer |
757M | 30 | -0.45 | 40 | 80 | - |
| SPRY NASDAQ ARS Pharmaceuticals |
Biotechnology
Intranasal Epinephrine, Allergy |
737M | 14 | -1.26 | 21 | 7 | - |
| ANRO NYSE Alto Neuroscience |
Pharmaceuticals
Antidepressants, Antipsychotics |
729M | 42 | -0.53 | 61 | 99 | - |
| RLMD NASDAQ Relmada Therapeutics |
Pharmaceuticals
Antidepressants, Bladder Cancer |
725M | 47 | 0.18 | 66 | 99 | - |
| BBOT NASDAQ BridgeBio Oncology |
Biotechnology
Cancer Therapeutics, Small |
706M | 15 | -1.18 | 28 | 11 | - |
| ALLO NASDAQ Allogene Therapeutics |
Biotechnology
CAR T Therapies, Gene Editing |
670M | 44 | 0.09 | 60 | 83 | - |
| CADL NASDAQ Candel Therapeutics |
Biotechnology
Cancer Immunotherapies, Viral |
643M | 33 | -0.33 | 62 | 89 | - |
| SLDB NASDAQ Solid Biosciences |
Biotechnology
Gene Therapies, Capsid Platforms |
637M | 44 | -0.92 | 62 | 84 | - |
| CLYM NASDAQ Climb Bio |
Biotechnology
Monoclonal Antibodies |
631M | 50 | 0.27 | 72 | 99 | - |
| ZVRA NASDAQ Zevra Therapeutics |
Biotechnology
Rare Disease Drugs, ADHD |
617M | 59 | -0.56 | 31 | 59 | - |
| CRMD NASDAQ CorMedix |
Pharmaceuticals
Antimicrobial Solutions, Catheter |
613M | 48 | -0.49 | 39 | 13 | - |
| ARVN NASDAQ Arvinas |
Pharmaceuticals
Protein Degraders, Cancer |
587M | 24 | -0.27 | 23 | 26 | - |
| VLA PA Valneva SE |
Biotechnology
Japanese Encephalitis, Cholera |
545M | 8 | -1.33 | 29 | 2 | - |
| ALT NASDAQ Altimmune |
Biotechnology
Obesity Treatments, Liver |
545M | 18 | -0.11 | 33 | 2 | - |
| MDXG NASDAQ MiMedx |
Biotechnology
Placental Allografts, Wound Care |
542M | 37 | -0.66 | 84 | 1 | - |
| IMMX NASDAQ Immix Biopharma |
Biotechnology
Cell Therapy, Immunotherapy |
541M | 46 | -0.04 | 69 | 97 | - |
| RIGL NASDAQ Rigel Pharmaceuticals |
Biotechnology
Hematology Drugs, Oncology Drugs |
537M | 44 | -0.79 | 33 | 15 | - |
| TECX NASDAQ Tectonic Therapeutic |
Biotechnology
Therapeutic Proteins, GPCR |
528M | 34 | -0.41 | 73 | 80 | - |
| XOMA NASDAQ XOMA |
Biotechnology
Biotech Royalties, Milestone |
524M | 60 | -0.33 | 32 | 87 | - |
| KYTX NASDAQ Kyverna Therapeutics |
Biotechnology
Cell Therapies, CAR T-Cells |
519M | 45 | -0.43 | 51 | 94 | - |
| CTNM NASDAQ Contineum Therapeutics |
Pharmaceuticals
Small Molecules, A1R Inhibitors |
513M | 42 | -0.32 | 57 | 91 | - |
| PRME NASDAQ Prime Medicine, Common Stock |
Biotechnology
Gene Editing, Genetic Medicines |
511M | 33 | -1.26 | 30 | 64 | - |
Technical
Structure
Fundamental
Topics in Industry »Biotechnology« (200+)
- Monoclonal Antibodies
- Oncology Drugs
- Small Molecules
- Immunotherapies
- Biopharmaceuticals
- Gene Therapies
- Cell Therapies
- Kinase Inhibitors
- Genetic Medicines
- Immunotherapy
- Cancer Therapeutics
- Cancer Therapies
- Oncology Therapeutics
- Bispecific Antibodies
- Antidepressants
- Immunology Drugs
- Antibodies
- Biotechnology
- Metabolic Treatments
- Fusion Proteins
- Gene Editing
- Rare Disease Drugs
- Antibiotics
- Enzyme Inhibitors
- Gene Therapy
- Anti-Inflammatory Drugs
- Clinical Therapeutics
- Drug Delivery
- Immunology Therapeutics
- Precision Medicines